trial · primary record
short dual antiplatelet therapy (DAPT) duration
Coronary Artery Disease (CAD)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1700 |
| Primary completion | 2029-10 |
| Primary endpoint | net clinical benefit |
| Registry ID | NCT07164859 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:51.874Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07164859
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.